Dow 
1.48% Nasdaq 1.73%
1.48% Nasdaq 1.73%Nov 27: 5.40 0.23 (4.09%)
0.23 (4.09%) Cypress Bioscience, Inc. (CYPB)
Compare CYPB to:
- Dow Jones (^DJI)
- NASDAQ (^IXIC)
- S&P 500 (^GSPC)
Cypress Bioscience, Inc.
(NasdaqGM: CYPB)After Hours: 5.63 N/A (N/A) 1:30pm ET
| Last Trade: | 5.40 |
|---|---|
| Trade Time: | Nov 27 |
| Change: | 0.23 (4.09%) |
| Prev Close: | 5.63 |
| Open: | 5.62 |
| Bid: | 5.30 x 100 |
| Ask: | 5.68 x 500 |
| 1y Target Est: | 9.83 |
| Day's Range: | 5.40 - 5.70 |
|---|---|
| 52wk Range: | 5.00 - 10.10 |
| Volume: | 402,056 |
| Avg Vol (3m): | 326,843 |
| Market Cap: | 206.79M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.80 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. For consolidated real-time quotes (incl. pre/post market data), sign up for a free trial of Real-time Quotes.
Headlines
| Fri, Nov 13 | CYPRESS BIOSCIENCE INC FinancialsEDGAR Online Financials |
| Fri, Nov 13 | Trading Outlook for Hard To Treat Diseases Inc. Issued by InvestorSoup.comGlobeNewswire |
| Mon, Nov 9 | Cypress Bioscience takes bigger loss as costs riseAP |
| Mon, Nov 9 | CYPRESS BIOSCIENCE INC Files SEC form 8-K, Results of Operations and Financial ConditionEDGAR Online |
| Mon, Nov 9 | UPDATE - Cypress Bioscience Q3 loss narrower than expectedat Reuters |
| Mon, Nov 9 | Cypress Bioscience Announces Third Quarter 2009 Financial ResultsMarketwire |
| Fri, Oct 30 | Cypress Biosci upgraded by OppenheimerBriefing.com |
| Fri, Oct 30 | Cypress Bioscience, Inc. to Present at Oppenheimer 20th Annual Healthcare ConferenceMarketwire |
| Thu, Oct 22 | Nibbles Here and There at Forest Labsat Motley Fool |
| Mon, Oct 19 | Forest, Cypress say Savella met goal in studyAP |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.